Immunovative Therapies Ltdis An Israeli Biopharmaceutical Company Based In Jerusalemwith Additional Operations In Shohamarizonaand Bangkokfounded In 2004The Company Focuses On Developingmanufacturingand Testing Next Generation Immunotherapiesparticularly Innovative Cancer Vaccinesthey Utilize Advanced Technologiesincluding The Mirror Effectaplatformto Create Anti Tumor Drugs That Aim To Replicate The Benefits Of Bone Marrow Or Stem Cell Transplants Without The Associated Toxicity The Company S Product Pipeline Features Several Cancer Therapiesincluding Allovaxa Personalized Vaccine For Head And Neck Neoplasms And Advanced Liver Cancerwhich Is Currently Undergoing Clinical Trialsthey Are Also Developing Cryovaxa Vaccine For Liver Cancerand An Individualized Cancer Vaccine For Hematologic Neoplasmsimmunovative Therapies Is Actively Conducting Clinical Trialsincluding Phase Ii Studies For Allovax And Cryovaxwith Plans To Advance To Phase Iii Trials For Drug Distribution Licensing
